This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Basch, E. Articles by Schrag, D. Search for Related Content PubMed PubMed Citation Articles by Basch, E. Articles by Schrag, D.

Patient Online Self-Reporting of Toxicity Symptoms During Chemotherapy

From the Departments of Epidemiology and Biostatistics, Medicine, Nursing, Information Services, and the Office of the Physician-in-Chief, Memorial Sloan-Kettering Cancer Center, New York, NY

Address reprint requests to Ethan Basch, MD, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E 63rd St, New York, NY 10021; e-mail: basche{at}mskcc.org

PURPOSE: Tracking symptoms related to treatment toxicity is standard practice in routine care and during clinical trials. Currently, clinicians collect symptom information via complex and often inefficient mechanisms, but there is growing interest in collecting outcome information directly from patients.

PATIENTS AND METHODS: The National Cancer Institute Common Terminology Criteria for Adverse Events schema for seven common symptoms was adapted into a Web-based patient-reporting system, accessible from desktop computers in outpatient clinics and from home computers. Eighty patients with gynecologic malignancies beginning standard chemotherapy regimens were enrolled between April and September 2004. During an 8-week observation period, participants were encouraged to log in and report symptoms at each follow-up visit, or alternatively, to access the system from home.

RESULTS: All patients completed an initial log in. At each subsequent appointment, most enrollees (80% to 85%) reported symptoms using the online system, with a mean of three follow-up visits per patient during the observation period (range, one to six). Sixty of 80 patients (75%) logged in at least once from home. Use was significantly associated with prior Internet experience. Forty-two severe toxicities (grade 3 to 4) entered from home prompted seven clinician interventions. Most patients (96%) found the system useful and would recommend it to others.

CONCLUSION: Patients are capable of reporting symptoms experienced during chemotherapy using a Web-based interface. Assessment in the clinical trial setting and comparison of direct patient- versus clinician-based approaches for reporting symptoms and their severity are warranted.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				E. Basch, A. Iasonos, A. Barz, A. Culkin, M. G. Kris, D. Artz, P. Fearn, J. Speakman, R. Farquhar, H. I. Scher, et al. Long-Term Toxicity Monitoring via Electronic Patient-Reported Outcomes in Patients Receiving Chemotherapy J. Clin. Oncol., December 1, 2007; 25(34): 5374 - 5380. [Abstract] [Full Text] [PDF]

				A. Trotti, A. D. Colevas, A. Setser, and E. Basch Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in Oncology J. Clin. Oncol., November 10, 2007; 25(32): 5121 - 5127. [Abstract] [Full Text] [PDF]

				J. Lipscomb, B. B. Reeve, S. B. Clauser, J. S. Abrams, D. Watkins Bruner, L. B. Burke, A. M. Denicoff, P. A. Ganz, K. Gondek, L. M. Minasian, et al. Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward J. Clin. Oncol., November 10, 2007; 25(32): 5133 - 5140. [Abstract] [Full Text] [PDF]

				E. Basch, D. Artz, A. Iasonos, J. Speakman, K. Shannon, K. Lin, C. Pun, H. Yong, P. Fearn, A. Barz, et al. Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities J. Am. Med. Inform. Assoc., May 1, 2007; 14(3): 264 - 268. [Abstract] [Full Text] [PDF]

				A. L. Stanton Psychosocial Concerns and Interventions for Cancer Survivors J. Clin. Oncol., November 10, 2006; 24(32): 5132 - 5137. [Abstract] [Full Text] [PDF]

				A E Fung, P J Rosenfeld, and E Reichel The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide Br. J. Ophthalmol., November 1, 2006; 90(11): 1344 - 1349. [Abstract] [Full Text] [PDF]

				L. Jalmsell, U. Kreicbergs, E. Onelov, G. Steineck, and J.-I. Henter Symptoms Affecting Children With Malignancies During the Last Month of Life: A Nationwide Follow-up Pediatrics, April 1, 2006; 117(4): 1314 - 1320. [Abstract] [Full Text] [PDF]